Brief: Hls Therapeutics Announces CEO Transition
17/04/2023 12:07
April 17 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES CEO TRANSITION
* HLS THERAPEUTICS INC - CRAIG MILLIAN TO REPLACE RETIRING
CEO,
GILBERT GODIN, ON MAY 1, 2023
* HLS THERAPEUTICS INC - CRAIG MILLIAN TO REPLACE RETIRING
CEO,
GILBERT GODIN, ON MAY 1, 2023
* HLS THERAPEUTICS INC - CRAIG MILLIAN TO REPLACE RETIRING
CEO,
GILBERT GODIN, ON MAY 1, 2023
* HLS THERAPEUTICS INC - GODIN WILL RETIRE FROM BOARD AND
MILLIAN
WILL BE APPOINTED TO BOARD ON MAY 1
Source text for Eikon: ID:nCNWdXJWfa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group